Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

Current Trends in Nursing I

Current Trends in Nursing I

Current trends in nursing include:

Current Trends in Nursing II

Current Trends in Nursing II

Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...

Methods of Documentation VI: Case Management Model

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dermatologists' Perspectives on Biosimilars.

Journal of drugs in dermatology : JDD·2024

Same author

Academy of Managed Care Pharmacy.

P & T : a peer-reviewed journal for formulary management·2017

Same author

American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting.

P & T : a peer-reviewed journal for formulary management·2017

Same author

Challenges and Solutions in Reducing Opioid Misuse and Abuse.

P & T : a peer-reviewed journal for formulary management·2017

Same author

Covering the Cost of the Cure: From Hepatitis C to Cancer, New Therapies Are Straining a System Plagued by Inefficiency.

P & T : a peer-reviewed journal for formulary management·2016

Same author

American Academy of Ophthalmology 2015 Annual Meeting.

P & T : a peer-reviewed journal for formulary management·2016

Same journal

Big pharma moves into biologics.

Biotechnology healthcare·2013

Same journal

Study: High Copayments Cut Biodrug Use up to 21 Percent.

Biotechnology healthcare·2013

Same journal

Avian flu and the quest for immunity: not just chicken feed.

Biotechnology healthcare·2013

Same journal

Variety of Biotech Therapies, Uses Take Prominence Among ASCO Presentations.

Biotechnology healthcare·2013

Same journal

Opening the door to follow-on proteins?

Biotechnology healthcare·2013

Same journal

On specialty pharmaceuticals: reflections of a second-year medical student.

Biotechnology healthcare·2013

See all related articles

Search research articles

Related Experiment Video

Updated: May 23, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Managing MS: Trends, Issues, and Perspectives.

Mari Edlin, Peter Sonnenreich

Biotechnology Healthcare

|April 6, 2012

Summary

This summary is machine-generated.

New oral medications for multiple sclerosis (MS) and expensive biologic drugs create challenges for healthcare stakeholders. Managing access and cost is crucial for patients with MS.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Related Experiment Videos

Last Updated: May 23, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Area of Science:

Neurology
Pharmacoeconomics
Health Policy

Background:

The landscape of multiple sclerosis (MS) treatment is evolving rapidly.
The introduction of oral disease-modifying therapies (DMTs) offers new options for MS management.
High-cost biologic drugs remain a significant component of MS treatment paradigms.

Purpose of the Study:

To analyze the emerging challenges in the multiple sclerosis (MS) market.
To examine the impact of oral MS medications and high-cost biologics on stakeholders.
To identify key considerations for navigating the evolving MS therapeutic environment.

Main Methods:

Review of current market trends in multiple sclerosis therapeutics.
Analysis of drug pricing and access strategies for oral and biologic MS medications.
Stakeholder impact assessment including patients, payers, and providers.

Main Results:

Oral medications for multiple sclerosis (MS) are increasingly available, altering treatment choices.
The high cost associated with biologic MS drugs presents significant economic challenges.
Stakeholders face complex decisions regarding treatment selection, cost-effectiveness, and patient access.

Conclusions:

The growing availability of oral MS therapies alongside costly biologics necessitates strategic planning.
Addressing the economic and access barriers is critical for ensuring equitable patient care in multiple sclerosis.
Future strategies must balance therapeutic innovation with financial sustainability in MS treatment.